DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 39 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,003 | +81.6% | 26,745 | +166.6% | 0.00% | – |
| Q4 2021 | $38,000 | -5.0% | 10,031 | 0.0% | 0.00% | – |
| Q3 2021 | $40,000 | -94.2% | 10,031 | -93.6% | 0.00% | -100.0% |
| Q2 2021 | $693,000 | -0.3% | 155,662 | +104.9% | 0.00% | 0.0% |
| Q1 2021 | $695,000 | +14.5% | 75,967 | +26.9% | 0.00% | 0.0% |
| Q4 2020 | $607,000 | – | 59,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 233,730 | $369,293 | 0.45% |
| COOPERMAN LEON G | 812,508 | $1,283,844 | 0.08% |
| CATALYST FINANCIAL PARTNERS LLC | 14,475 | $22,872 | 0.01% |
| Legend Financial Advisors, Inc. | 1,000 | $1,580 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 184,870 | $292 | 0.00% |
| STATE STREET CORP | 133,258 | $210,548 | 0.00% |
| MORGAN STANLEY | 55,201 | $87,223 | 0.00% |
| BlackRock Inc. | 69,937 | $110,508 | 0.00% |
| Bank of New York Mellon Corp | 36,062 | $56,982 | 0.00% |
| Citadel Advisors | 1,600 | $2,528 | 0.00% |